Mohini Health & Hygiene Ltd
Incorporated in 2009, Mohini Health and Hygiene Ltd is in the business of healthcare and hygiene products[1]
- Market Cap ₹ 73.8 Cr.
- Current Price ₹ 40.4
- High / Low ₹ 66.0 / 33.1
- Stock P/E 22.6
- Book Value ₹ 55.6
- Dividend Yield 0.00 %
- ROCE 13.9 %
- ROE 9.81 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.73 times its book value
- Debtor days have improved from 59.5 to 39.5 days.
Cons
- The company has delivered a poor sales growth of 5.33% over past five years.
- Company has a low return on equity of 9.53% over last 3 years.
- Earnings include an other income of Rs.5.92 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 169 | 147 | 129 | 137 | 136 | 192 | 200 | 168 | 150 | |
| 152 | 127 | 119 | 120 | 126 | 179 | 186 | 155 | 150 | |
| Operating Profit | 17 | 20 | 11 | 18 | 11 | 13 | 14 | 12 | 0 |
| OPM % | 10% | 14% | 8% | 13% | 8% | 7% | 7% | 7% | 0% |
| 1 | 1 | 6 | 0 | 7 | 6 | 8 | 4 | 6 | |
| Interest | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 4 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 |
| Profit before tax | 7 | 10 | 8 | 8 | 9 | 11 | 13 | 8 | -2 |
| Tax % | 30% | 27% | 16% | 25% | 30% | 36% | 20% | 31% | |
| 5 | 7 | 7 | 6 | 6 | 7 | 11 | 6 | -3 | |
| EPS in Rs | 2.74 | 4.02 | 3.58 | 3.25 | 3.15 | 3.72 | 5.86 | 3.21 | -1.61 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 7% |
| TTM: | -21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 22% |
| TTM: | -69% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | -7% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 10% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 | 83 |
| 50 | 44 | 35 | 43 | 44 | 28 | 23 | 35 | 37 | |
| 29 | 23 | 27 | 26 | 30 | 21 | 17 | 28 | 36 | |
| Total Liabilities | 138 | 133 | 134 | 147 | 157 | 138 | 140 | 168 | 174 |
| 65 | 64 | 61 | 65 | 53 | 49 | 45 | 42 | 41 | |
| CWIP | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 6 | 7 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 |
| 73 | 69 | 71 | 81 | 104 | 89 | 93 | 118 | 123 | |
| Total Assets | 138 | 133 | 134 | 147 | 157 | 138 | 140 | 168 | 174 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 3 | 14 | 16 | 10 | -5 | 26 | 14 | 30 | |
| -6 | -4 | -2 | -8 | 8 | -6 | -1 | -29 | |
| 5 | -12 | -14 | -3 | -3 | -20 | -10 | 8 | |
| Net Cash Flow | 2 | -2 | 1 | -0 | 0 | 0 | 4 | 9 |
| Free Cash Flow | -3 | 10 | 14 | 2 | 3 | 23 | 12 | 5 |
| CFO/OP | 23% | 79% | 151% | 58% | -30% | 217% | 121% | 270% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 79 | 65 | 60 | 62 | 109 | 67 | 72 | 39 |
| Inventory Days | 38 | 65 | 94 | 127 | 110 | 65 | 55 | 117 |
| Days Payable | 30 | 14 | 30 | 36 | 43 | 16 | 10 | 29 |
| Cash Conversion Cycle | 87 | 116 | 124 | 153 | 175 | 116 | 117 | 127 |
| Working Capital Days | 39 | 54 | 65 | 63 | 95 | 96 | 106 | 101 |
| ROCE % | 14% | 11% | 11% | 10% | 12% | 14% | 14% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Installed Capacity - Bleached Absorbent Cotton Metric Tonnes ・Standalone data |
|
||||||||||
| Export Revenue Contribution % ・Standalone data |
|||||||||||
| Employee Strength Number ・Standalone data |
|||||||||||
| Actual Production Volume - Bleached Cotton Metric Tonnes ・Standalone data |
|||||||||||
| Installed Capacity - Surgical Cotton Products Metric Tonnes ・Standalone data |
|||||||||||
| Capacity Utilization Rate % ・Standalone data |
|||||||||||
Documents
Announcements
-
Disclosure under SEBI Takeover Regulations
9 April 2026 - Bansal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
9 April 2026 - Mohini Health & Hygiene confirms corporate governance provisions are not applicable, except Regulation 23 from April 1, 2025.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
8 April 2026 - Regulation 74(5) certificate issued for quarter ended March 31, 2026.
-
Trading Window
27 March 2026 - Trading window closed from 01-Apr-2026 until 48 hours after audited FY2026 results.
-
General Updates
27 March 2026 - Mohini Health awarded Ecovadis Bronze, 65/100, 69th percentile (Top 35%), assessed March 26, 2026.
Business Overview:[1]
Company deals in processing of raw cotton, trading in cotton yarn and textile fabric, and has diversified into the health and hygiene sector, beauty, hospital disposables, surgical consumables, and baby care. They offer 100% Absorbent Bleached Cotton and 100% Absorbent Bleached Comber (both conventional and organic)